Investment Activity Cherrystone Angel Group has a strong track record of investing over $25 million across 26 companies and participating in more than 80 funding rounds, indicating active engagement in the early-stage investment market with potential opportunities to collaborate or co-invest.

Emerging Portfolio Recent investments in innovative startups like Lenoss Medical highlight their focus on biomedical and health tech sectors, presenting opportunities for companies targeting healthcare innovation or medical device markets.

Market Positioning As a leading angel investor in New England and New York with a collection of notable exits such as Medumo and Streamroot, they are well-positioned to identify promising startups, making them an ideal partner for early-stage funding or strategic alliances.

Growth Metrics With annual revenues estimated between one and ten million dollars and an active investment portfolio, there is potential for sales collaborations in the healthcare, biotech, and innovative technology sectors aiming to reach similar revenue milestones.

Technology & Outreach Utilizing a modern tech stack and maintaining an active web presence, Cherrystone Angel Group is accessible for outreach, offering opportunities for technology providers, marketing partners, or platform integrations to enhance their investment processes.